Skip to main content

Advertisement

SpringerLink
Log in

Exhaled nitric oxide in the clinical management of asthma

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Management of asthma has gradually evolved from the concept of controlling bronchial hyperresponsiveness to focusing on control of inflammation. The awareness of airway remodeling, and the emergence of data suggesting irreversibility of some of these changes, despite standard-of-care pharmacotherapies such as inhaled steroids, has highlighted the need for early detection; effective diagnosis and treatment; monitoring responses and adhering to treatment; and predicting exacerbations. Pre-clinical intervention strategies targeted toward picking up early suggestions of asthma before irreversible airway changes occur may open the door to primary prevention approaches. Although invasive methods, such as bronchial biopsy, remain the gold standard to understanding and treating asthma, there is a preference for noninvasive techniques for reasons of convenience, ease of use, and patient comfort. In this article, recent data that support the use of exhaled nitric oxide as a noninvasive biomarker of inflammation in clinical practice are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Apter AJ, Szefler SJ: Advances in adult and pediatric asthma. J Allergy Clin Immunol 2004, 113:407–414.

    Article  PubMed  Google Scholar 

  2. Zeiger RS, Dawson C, Weiss S: Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 1999, 103(3 Pt 1):376–387.

    Article  PubMed  CAS  Google Scholar 

  3. Nielsen KG, Bisgaard H: Lung function response to cold air challenge in asthmatic and healthy children of 2–5 years of age. Am J Respir Crit Care Med 2000, 161:1805–1809.

    PubMed  CAS  Google Scholar 

  4. Badr-el-Din OM, el-Sawy IH, el-Azzouni OE, et al.: Eosinophil cationic protein as a serological marker of disease activity in childhood bronchial asthma. East Mediterr Health J 1999, 5:664–675.

    PubMed  CAS  Google Scholar 

  5. Warner JO: A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months’ treatment and 18 months’ posttreatment follow-up. J Allergy Clin Immunol 2001, 108:929–937.

    Article  PubMed  CAS  Google Scholar 

  6. Bates CA, Silkoff PE: Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol 2003, 111:256–262.

    Article  PubMed  CAS  Google Scholar 

  7. Santanello NC, Demuro-Mercon C, Davies G, et al.: Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol 2000, 106:861–866.

    Article  PubMed  CAS  Google Scholar 

  8. Berlyne GS, Parameswaran K, Kamada D, et al.: A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000, 106:638–644.

    Article  PubMed  CAS  Google Scholar 

  9. Hunt J: Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002, 110:28–34.

    Article  PubMed  Google Scholar 

  10. Bhagat K, Vallance P: Nitric oxide 9 years on. J R Soc Med 1996, 89:667–673.

    PubMed  CAS  Google Scholar 

  11. Dinakar C, Malur A, Raychaudhuri B, et al.: Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann Allergy Asthma Immunol 1999, 82:217–222.

    PubMed  CAS  Google Scholar 

  12. Guo FH, Comhair SA, Zheng S, et al.: Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol 2000, 164:5970–5980.

    PubMed  CAS  Google Scholar 

  13. Gao PS, Kawada H, Kasamatsu T, et al.: Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun 2000, 267:761–763.

    Article  PubMed  CAS  Google Scholar 

  14. Hamid Q, Springall DR, Riveros-Moreno V, et al.: Induction of nitric oxide synthase in asthma. Lancet 1993, 342:1510–1513.

    Article  PubMed  CAS  Google Scholar 

  15. Thomassen MJ, Raychaudhuri B, Dweik RA, et al.: Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol 1999, 104:1174–1182.

    Article  PubMed  CAS  Google Scholar 

  16. Gustafsson LE, Leone AM, Persson MG, et al.: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991, 181:852–857.

    Article  PubMed  CAS  Google Scholar 

  17. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993, 6:1368–1370.

    PubMed  CAS  Google Scholar 

  18. Kharitonov SA, Yates DH, Chung KF, Barnes PJ: Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996, 9:196–201.

    Article  PubMed  CAS  Google Scholar 

  19. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J 2000, 16:781–792.

    Article  PubMed  CAS  Google Scholar 

  20. Kharitonov SA, Chung KF, Evans D, et al.: Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996, 153(6 Pt 1):1773–1780.

    PubMed  CAS  Google Scholar 

  21. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999, 160:2104–2117.

  22. Baraldi E, de Jongste JC: Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002, 20:223–237. Describes consensus guidelines between the American Thoracic Society and the European Respiratory Society for measurement of exhaled nitric oxide in children.

    Article  PubMed  CAS  Google Scholar 

  23. Henriksen AH, Sue-Chu M, Lingaas Holmen T, et al.: Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999, 13:301–306.

    Article  PubMed  CAS  Google Scholar 

  24. Chatkin JM, Ansarin K, Silkoff PE, et al.: Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999, 159:1810–1813.

    PubMed  CAS  Google Scholar 

  25. Dupont LJ, Demedts MG, Verleden GM: Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003, 123:751–756. This study showed that exhaled NO in the study population, at a cutoff level of 16 parts per billion, had a specificity for the diagnosis of asthma of 90% and a positive predictive value of more than 90%.

    Article  PubMed  CAS  Google Scholar 

  26. Scollo M, Zanconato S, Ongaro R, et al.: Exhaled nitric oxide and exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 2000, 161(3 Pt 1):1047–1050.

    PubMed  CAS  Google Scholar 

  27. Deykin A, Massaro AF, Drazen JM, Israel E: Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med 2002, 165:1597–1601. This study showed that receiver operating characteristic (ROC) curves for the diagnosis of asthma indicated that FENO is a robust discriminator between individuals with asthma and healthy subjects. These data indicate that the choice of expiratory flow rate and collection method can be based on practicality and patient comfort without compromising the utility of this test for asthma.

    Article  PubMed  Google Scholar 

  28. Payne DN, Adcock IM, Wilson NM, et al.: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001, 164(8 Pt 1):1376–1381.

    PubMed  CAS  Google Scholar 

  29. van den Toorn LM, Prins JB, Overbeek SE, et al.: Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000, 162(3 Pt 1):953–957.

    Google Scholar 

  30. Dupont LJ, Rochette F, Demedts MG, Verleden GM: Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998, 157(3 Pt 1):894–898.

    PubMed  CAS  Google Scholar 

  31. Ludviksdottir D, Janson C, Hogman M, et al.: Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir Med 1999, 93:552–556.

    Article  PubMed  CAS  Google Scholar 

  32. Salome CM, Roberts AM, Brown NJ, et al.: Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med 1999, 159:911–916.

    PubMed  CAS  Google Scholar 

  33. Baraldi E, Carra S, Dario C, et al.: Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med 1999, 159:262–266.

    PubMed  CAS  Google Scholar 

  34. Dweik RA, Comhair SA, Gaston B, et al.: NO chemical events in the human airway during the immediate and late antigeninduced asthmatic response. Proc Natl Acad Sci U S A 2001, 98:2622–2627.

    Article  PubMed  CAS  Google Scholar 

  35. Jones SL, Kittelson J, Cowan JO, et al.: The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001, 164:738–743.

    PubMed  CAS  Google Scholar 

  36. Bratton DL, Lanz MJ, Miyazawa N, et al.: Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr Pulmonol 1999, 28:402–407.

    Article  PubMed  CAS  Google Scholar 

  37. Stirling RG, Kharitonov SA, Campbell D, et al.: Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax 1998, 53:1030–1034.

    PubMed  CAS  Google Scholar 

  38. Silkoff PE, McClean P, Spino M, et al.: Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001, 119:1322–1328.

    Article  PubMed  CAS  Google Scholar 

  39. Lanz MJ, Leung DY, White CW: Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Ann Allergy Asthma Immunol 1999, 82:161–164.

    Article  PubMed  CAS  Google Scholar 

  40. Little SA, Chalmers GW, MacLeod KJ, et al.: Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000, 55:232–234.

    Article  PubMed  CAS  Google Scholar 

  41. Silkoff PE, Romero FA, Gupta N, et al.: Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody. Pediatrics 2004, 113:e308–312.

    Article  PubMed  Google Scholar 

  42. Sippel JM, Holden WE, Tilles SA, et al.: Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000, 106:645–650. This study showed that exhaled NO was significantly correlated with the following markers of asthma disease control: asthma symptoms within the past 2 weeks, dyspnea score, daily use of rescue medications, and reversibility of airflow obstruction, but not with markers of asthma severity.

    Article  PubMed  CAS  Google Scholar 

  43. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454–457.

    PubMed  CAS  Google Scholar 

  44. Beck-Ripp J, Griese M, Arenz S, et al.: Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002, 19:1015–1019.

    Article  PubMed  CAS  Google Scholar 

  45. Kharitonov SA, Donnelly LE, Montuschi P, et al.: Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002, 57:889–896.

    Article  PubMed  CAS  Google Scholar 

  46. Withers NJ, Low L, Holgate ST, Clough JB: The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med 1998, 158:352–357.

    PubMed  CAS  Google Scholar 

  47. Henriksen AH, Lingaas-Holmen T, Sue-Chu M, Bjermer L: Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey. Eur Respir J 2000, 15:849–855.

    Article  PubMed  CAS  Google Scholar 

  48. Moody A, Fergusson W, Wells A, et al.: Increased nitric oxide production in the respiratory tract in asymptomatic Pacific Islanders: an association with skin prick reactivity to house dust mite. J Allergy Clin Immunol 2000, 105:895–899.

    Article  PubMed  CAS  Google Scholar 

  49. de Kluijver J, Evertse CE, Schrumpf JA, et al.: Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids. Am J Respir Crit Care Med 2002, 166:294–300.

    Article  PubMed  Google Scholar 

  50. New NHLBI guidelines for the diagnosis and management of asthma. National Heart, Lung and Blood Institute. Lippincott Health Promot Lett 1997, 2:1, 8–9.

Download references

Author information

Authors and Affiliations

  1. Section of Allergy/Asthma/Immunology, Children’s Mercy Hospital, 2401 Gillham Road, 64108, Kansas City, MO, USA

    Chitra Dinakar MD

Authors
  1. Chitra Dinakar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinakar, C. Exhaled nitric oxide in the clinical management of asthma. Curr Allergy Asthma Rep 4, 454–459 (2004). https://doi.org/10.1007/s11882-004-0011-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-004-0011-7

Keywords

Search

Navigation